Comparative study of the effectiveness of two mouthwashes in reducing gingival inflammation in hospitalized patients
Phase 2
Active, not recruiting
- Conditions
- Periodontal disease, unspecified
- Registration Number
- RBR-8x7534h
- Lead Sponsor
- Hospital de Messejana Dr. Carlos Alberto Studart Gomes
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Normosystemic patients; of both sexes; aged between 30 and 65 years; oriented and cooperative; with autonomy to promote self-care regarding oral hygiene and with a mouthing and spitting reflex; presenting gingivitis and admitted to a ward
Exclusion Criteria
Confirmed history of allergy to Chloramine T 0.2% and Chlorhexidine 0.12% or components of formulas; pregnant or breastfeeding women; presence of infections in the oral cavity; patients with impaired self-care; individuals with a history of adverse reactions to chlorhexidine or components of the formula; patients/guardians who did not sign the free and informed consent form
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome will be the assessment of the effectiveness of the substances tested in reduction of gingival inflammation in hospitalized patients. To evaluate the reduction of gingival inflammation, the Löe Gingival Index will be performed with a periodontal probe for PSR (Golgran) in four sites per tooth, these being: mesio-buccal, mesio-lingual, disto-buccal and disto-lingual. The sum of these values divided by four (number of sites)<br>will result in the gingival index for the evaluated tooth. The sum of the gingival indices of each tooth, divided by the number of teeth examined, will result in the index per patient. This assessment will take place immediately before starting administration of the solutions and will be repeated every five days from the start of treatment, totaling fifteen days of administration of the solutions and four assessments. The results of the Löe Gingival Index will be computed in individual clinical records.
- Secondary Outcome Measures
Name Time Method ão são esperados desfechos secundários.